Co-Authors
This is a "connection" page, showing publications co-authored by Alan Go and Kristi Reynolds.
Connection Strength
4.540
-
Rule-based natural language processing to examine variation in worsening heart failure hospitalizations by age, sex, race and ethnicity, and left ventricular ejection fraction. Am Heart J. 2024 Dec; 278:117-126.
Score: 0.234
-
The anticoagulation length of therapy and risk of new adverse events in venous thromboembolism (ALTERNATIVE) study: Design and survey results. PLoS One. 2022; 17(12):e0277961.
Score: 0.207
-
Health Literacy and Treatment Satisfaction Among Patients with Venous Thromboembolism. J Gen Intern Med. 2022 Nov 03.
Score: 0.206
-
Thromboembolism after treatment with 4-factor prothrombin complex concentrate or plasma for warfarin-related bleeding. J Thromb Thrombolysis. 2022 Oct; 54(3):470-479.
Score: 0.203
-
Health-related quality of life associated with warfarin and direct oral anticoagulants in venous thromboembolism. Thromb Res. 2022 Aug; 216:97-102.
Score: 0.201
-
Multimorbidity Burden and Incident Heart Failure Among People With and Without HIV: The HIV-HEART Study. Mayo Clin Proc Innov Qual Outcomes. 2022 Jun; 6(3):218-227.
Score: 0.199
-
Management of Adults with Newly Diagnosed Atrial Fibrillation with and without CKD. J Am Soc Nephrol. 2022 Feb; 33(2):442-453.
Score: 0.194
-
Human Immunodeficiency Virus Infection and Variation in Heart Failure Risk by Age, Sex, and Ethnicity: The HIV HEART Study. Mayo Clin Proc. 2021 Dec 11.
Score: 0.193
-
Human immunodeficiency virus infection and risks of morbidity and death in adults with incident heart failure. Eur Heart J Open. 2021 Nov; 1(3):oeab040.
Score: 0.193
-
COVID-19 and Risk of VTE in Ethnically Diverse Populations. Chest. 2021 Jul 19.
Score: 0.188
-
Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism. J Thromb Thrombolysis. 2021 Apr 08.
Score: 0.185
-
Noncardiac-Related Morbidity, Mobility Limitation, and Outcomes in Older Adults With Heart Failure. J Gerontol A Biol Sci Med Sci. 2020 09 25; 75(10):1981-1988.
Score: 0.178
-
Comparison of Long-Term Adverse Outcomes in Patients With Atrial Fibrillation Having Ablation Versus Antiarrhythmic Medications. Am J Cardiol. 2020 02 15; 125(4):553-561.
Score: 0.168
-
Incident Anemia in Older Adults with Heart Failure Rate, Etiology, and Association with Outcomes. Eur Heart J Qual Care Clin Outcomes. 2019 Mar 07.
Score: 0.160
-
Multimorbidity Burden and Adverse Outcomes in a Community-Based Cohort of Adults with Heart Failure. J Am Geriatr Soc. 2018 Dec; 66(12):2305-2313.
Score: 0.155
-
Association of Burden of Atrial Fibrillation With Risk of Ischemic Stroke in Adults With Paroxysmal Atrial Fibrillation: The KP-RHYTHM Study. JAMA Cardiol. 2018 Jul 01; 3(7):601-608.
Score: 0.152
-
Long-term Outcomes Associated With Implantable Cardioverter Defibrillator in Adults With Chronic Kidney Disease. JAMA Intern Med. 2018 03 01; 178(3):390-398.
Score: 0.149
-
Contemporary Procedural Complications, Hospitalizations, and Emergency Visits After Catheter Ablation for Atrial Fibrillation. Am J Cardiol. 2018 03 01; 121(5):602-608.
Score: 0.147
-
Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators. Heart. 2017 04; 103(7):529-537.
Score: 0.135
-
Trends in Incidence of Hospitalized Acute Myocardial Infarction in the Cardiovascular Research Network (CVRN). Am J Med. 2017 Mar; 130(3):317-327.
Score: 0.135
-
Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study. Circ Arrhythm Electrophysiol. 2015 Feb; 8(1):49-58.
Score: 0.119
-
A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score. J Am Heart Assoc. 2013 Jun 21; 2(3):e000250.
Score: 0.108
-
The Cardiovascular Research Network: a new paradigm for cardiovascular quality and outcomes research. Circ Cardiovasc Qual Outcomes. 2008 Nov; 1(2):138-47.
Score: 0.078
-
Initial antiretroviral therapy regimen and risk of heart failure. AIDS. 2023 Nov 14.
Score: 0.055
-
Variation in Heart Failure Risk by HIV Severity and Sex in People With HIV Infection. J Acquir Immune Defic Syndr. 2022 10 01; 91(2):175-181.
Score: 0.051
-
Diagnostic Yield, Outcomes, and Resource Utilization With Different Ambulatory Electrocardiographic Monitoring Strategies. Am J Cardiol. 2021 Dec 22.
Score: 0.048
-
Physician adjudication of angioedema diagnosis codes in a population of patients with heart failure prescribed angiotensin-converting enzyme inhibitor therapy. Pharmacoepidemiol Drug Saf. 2021 12; 30(12):1630-1634.
Score: 0.048
-
A reduced transferrin saturation is independently associated with excess morbidity and mortality in older adults with heart failure and incident anemia. Int J Cardiol. 2020 06 15; 309:95-99.
Score: 0.043
-
Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation. Circ Cardiovasc Qual Outcomes. 2019 11; 12(11):e006212.
Score: 0.042
-
Influence of Multimorbidity on Burden and Appropriateness of Implantable Cardioverter-Defibrillator Therapies. J Am Geriatr Soc. 2019 Mar 20.
Score: 0.040
-
Risk factors for medication non-adherence among atrial fibrillation patients. BMC Cardiovasc Disord. 2019 Feb 11; 19(1):38.
Score: 0.040
-
Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter-Defibrillators in the Cardiovascular Research Network. J Am Heart Assoc. 2018 Mar 26; 7(7).
Score: 0.037
-
Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators. J Am Heart Assoc. 2017 Nov 09; 6(11).
Score: 0.036
-
Health Literacy and Awareness of Atrial Fibrillation. J Am Heart Assoc. 2017 Apr 11; 6(4).
Score: 0.035
-
Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke. J Am Geriatr Soc. 2017 Feb; 65(2):241-248.
Score: 0.034
-
Comparative Effectiveness of Statin Therapy in Chronic Kidney Disease and Acute Myocardial Infarction: A Retrospective Cohort Study. Am J Med. 2015 Nov; 128(11):1252.e1-1252.e11.
Score: 0.031
-
Age and sex differences in long-term outcomes following implantable cardioverter-defibrillator placement in contemporary clinical practice: findings from the Cardiovascular Research Network. J Am Heart Assoc. 2015 Jun 02; 4(6):e002005.
Score: 0.031
-
Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts). Am J Cardiol. 2015 Jan 01; 115(1):40-6.
Score: 0.029
-
Geographic variation in cardiovascular procedure use among Medicare fee-for-service vs Medicare Advantage beneficiaries. JAMA. 2013 Jul 10; 310(2):155-62.
Score: 0.027
-
Longitudinal study of implantable cardioverter-defibrillators: methods and clinical characteristics of patients receiving implantable cardioverter-defibrillators for primary prevention in contemporary practice. Circ Cardiovasc Qual Outcomes. 2012 Nov; 5(6):e78-85.
Score: 0.026